Movement Alert｜Elevance Health Intraday Rise 3.01% in Regular Trading, Q3 Beat and Raised Outlook Support Shares

Market Focus10-22

On October 22, Elevance Health rose 3.01% in Regular Trading, trading near $447.18 per share, with turnover of $127 million.

The move was supported by a strong quarterly report and a fresh price-target increase. Elevance Health reported third-quarter adjusted EPS of $6.99, above consensus expectations of about $4.68 to $4.71, while revenue reached $50.44 billion versus market expectations near $49.22 billion. The company also raised its full-year adjusted EPS guidance to at least $29 from at least $27, above the $27.26 consensus expectation.

Follow-through came from analyst action after the results, with Leerink Partners raising its price target to $450 from $395. Broader analyst sentiment also remained constructive, with the mean target around $469.05, reinforcing market recognition of improving fundamentals.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment